Immunovant (IMVT)
(Delayed Data from NSDQ)
$30.92 USD
+0.41 (1.34%)
Updated Jul 16, 2024 04:00 PM ET
After-Market: $30.92 0.00 (0.00%) 5:26 PM ET
4-Sell of 5 4
D Value D Growth C Momentum F VGM
Brokerage Reports
Immunovant, Inc. [IMVT]
Reports for Purchase
Showing records 101 - 105 ( 105 total )
Company: Immunovant, Inc.
Industry: Medical - Biomedical and Genetics
No Power, No Problem, as IMVT-1401 Hits Stat Sig in MG Trial; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Immunovant, Inc.
Industry: Medical - Biomedical and Genetics
First Quarter Financial Update for Immunovant; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Immunovant, Inc.
Industry: Medical - Biomedical and Genetics
Company: Immunovant, Inc.
Industry: Medical - Biomedical and Genetics
SC Formulation Should Secure a Place in the Blockbuster FcRn Space; Initiate With Buy and $34 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D
Company: Immunovant, Inc.
Industry: Medical - Biomedical and Genetics
KOL Perspectives on FcRn''s for the Treatment of Myasthenia Gravis
Provider: H.C. Wainwright & Co., Inc.
Analyst: TSAO D